Latest News

eye on pharma banner
Eye on Pharma: BI Cyltezo Partnership; Europe Ustekinumab Launch; Mexico Biosimilar Approval

July 24th 2024

Boehringer Ingelheim (BI) partners with GoodRx to offer Cyltezo, an adalimumab biosimilar, to patients; a new ustekinumab biosimilar launches in Europe; and Mexican officials approve a bevacizumab biosimilar.

AI generated image of joint issues in rheumatology | Image credit: JK_kyoto - stock.adobe.com
Switching Patterns Highlight Nocebo Effect in European Patients Using Amgevita

July 23rd 2024

Rheumatoid arthritis treatment. | Image Credit: MicroOne - stock.adobe.com
Biosimilar DMARDs Offer Cost-Effective Option for Patients With RA After Failed Methotrexate Treatment

July 15th 2024

Eye on Pharma banner
Eye on Pharma: EU Biosimilar Approval, Launches and Product Returns, Denosumab Switching Data

July 10th 2024

doctor patient biosimilar | Image credit: Prostock-studio - stock.adobe.com
Samsung Bioepis’ Ustekinumab Biosimilar Demonstrates PK Equivalence in Healthy Adults

July 6th 2024

Video Series
Video Interviews
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcas
CFB podcast banner
CFB podcast banner
cfb podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.